Filters

Pp-197 manufacturers

Filters

None products found

pp-197

Solution for infusion

Dossier type
US CTD
Dossier status
Under development
Country of origin
United States
GMP approvals
FDA
Comments
Indication: Hypoplastic left heart syndrome (HLHS) — cardiac regenerative therapy in paediatric patients post-Norwood procedure Clinical stage: Phase 2b Modality: Biological (allogeneic mesenchymal stem/stromal cell therapy — off-the-shelf) Mechanism / Target: Allogeneic human cardiac-derived mesenchymal stem cells (Lomecel-B); promotes cardiac regeneration, angiogenesis, and anti-inflammatory remodelling via paracrine cytokine and exosome signalling; improves ventricular function and reduces vascular resistance Route / form: IV infusion (intracoronary or IV) Differentiation: Only cell therapy in active clinical development for HLHS;
Manufacturer #39336
US-based clinical-stage regenerative medicine company developing Rx allogeneic cell-based therapies for aging-related and other serious conditions. Lead biologic is advancing through multiple mid-stage clinical studies. Listed on a US exchange.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.